Update on bone-modifying agents in metastatic breast cancer. Academic Article

abstract

• Advances in the development of bone-modifying agents have led to the approval of new drugs for the prevention and treatment of skeletal-related events in patients with bone metastases from breast cancer. In light of these advances, the American Society of Clinical Oncology has published a guideline update. 2011 Macmillan Publishers Limited. All rights reserved.

authors

• Suva, Larry

published proceedings

• Nat Rev Endocrinol

author list (cited authors)

• Suva, L. J., Brander, B. E., & Makhoul, I.

citation count

• 9

complete list of authors

• Suva, Larry J||Brander, Brooke E||Makhoul, Issam

publication date

• May 2011

publisher

• Springer Nature  Publisher

published in

• n1759-5029ISSN  Journal

keywords

• Bone Density Conservation Agents
• Bone Neoplasms
• Breast Neoplasms
• Clinical Trials As Topic
• Female
• Fractures, Bone
• Humans
• Practice Guidelines As Topic
• Societies, Medical

PubMed Central ID

• 21610686

Digital Object Identifier (DOI)

• 10.1038/nrendo.2011.80

start page

• 380

end page

• 381

volume

• 7

issue

• 7

URL

• http://dx.doi.org/10.1038/nrendo.2011.80